Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.147
Neutral
RSI(14)
53.736
Neutral
STOCH(KDJ)(9,3,3)
59.081
Buy
ATR(14)
2.781
High Vlolatility
CCI(14)
-3.231
Neutral
Williams %R
49.274
Neutral
TRIX(12,20)
0.120
Sell
StochRSI(14)
79.660
Sell
Search
Dexcom Inc
DXCMAdd to Watchlist
83.950USD
+9.410+12.62%
Market hours （ET）Quotes delayed by 15 min
32.40BMarket Cap
35.10P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+12.62%
5 Days
+19.10%
1 Month
+24.64%
6 Months
+14.93%
Year to Date
+26.48%
1 Year
-5.75%
Key Figures
80.000Open
84.700High
8.61MVolume
35.10P/E TTM
27.33P/E Dynamic
--Dividend TTM
2.23%Turnover Ratio
74.540Prev. Close
79.665Low
478.95MTurnover
56.22P/E Static
10.96P/B
0.00%Div Yield TTM
13.90%ROA
89.98052wk High
2.13Volume Ratio
576.20MNet Profit
385.90MShares
2.3918EPS TTM
1.44Beta
35.62%ROE
54.11052wk Low
6.75%Amplitude
62.95%Gross Margin
32.40BMarket Cap
3.66Reward/Risk
2.25%Risk Rate
TradingKey Stock Score of Dexcom Inc
Currency: USD Updated: 2026-07-30Key Insights
Dexcom Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 86.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Dexcom Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
15°C
Very Low
Very High
Neutral
Dexcom Inc Highlights
StrengthsRisks
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 28.70% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.66B.
Undervalued
The company’s latest PE is 31.16, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 384.48M shares, decreasing 5.90% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.07.
Analyst Rating
Based on
30
analysts
Buy
Current Rating
86.498
Target Price
+17.89%
Upside Space
Dexcom Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
30
analysts
Buy
Current Rating
86.498
Target Price
+15.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Dexcom Inc
DXCM
30
Medtronic PLC
MDT
33
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Medline Ord Shs Class A
MDLN
29
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
73.888
Buy
MA10
73.844
Buy
MA20
73.943
Buy
MA50
72.803
Buy
MA100
67.987
Buy
MA200
67.655
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Dexcom Inc Info
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Ticker SymbolDXCM
CompanyDexcom Inc
CEOMr. Jacob Steven (Jake) Leach
Websitehttps://www.dexcom.com/
Shareholders
Related Instruments
-0.81%
-0.16%
+0.42%
+0.19%
-0.17%
+0.46%
-6.15%
+0.15%
+1.75%
+0.29%
-1.91%
+1.11%
-0.16%
-0.49%
+0.17%
-0.21%
-0.36%
+0.30%
-1.03%
-0.32%Popular Instruments
52568.900
+299.900 (+0.57%)
28329.000
+130.500 (+0.46%)
7498.400
+54.100 (+0.73%)
14759.000
-80.000 (-0.54%)
63385.000
-209.000 (-0.33%)
6370.500
+4.100 (+0.06%)
83.894
+0.724 (+0.87%)
305.115
-28.315 (-8.49%)
200.815
+5.775 (+2.96%)
4050.340
-52.490 (-1.28%)
FAQs
What is the current price of Dexcom Inc (DXCM)?
The current price of Dexcom Inc (DXCM) is 74.57.
What is the symbol of Dexcom Inc?
The ticker symbol of Dexcom Inc is DXCM.
What is the 52-week high of Dexcom Inc?
The 52-week high of Dexcom Inc is 89.98.
What is the 52-week low of Dexcom Inc?
The 52-week low of Dexcom Inc is 54.11.
What is the market capitalization of Dexcom Inc?
The market capitalization of Dexcom Inc is 28.78B.
Is Dexcom Inc (DXCM) currently rated as Buy, Hold, or Sell?
According to analysts, Dexcom Inc (DXCM) has an overall rating of Buy, with a price target of 86.50.
What is the Earnings Per Share (EPS TTM) of Dexcom Inc (DXCM)?
The Earnings Per Share (EPS TTM) of Dexcom Inc (DXCM) is 2.14.